ArticleCancers2021

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma.

Eileen Shiuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.